Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.

Paunovic V, Carroll HP, Vandenbroeck K, Gadina M.

Rheumatology (Oxford). 2008 Jun;47(6):771-6. doi: 10.1093/rheumatology/kem352. Epub 2008 Jan 31. Review.

PMID:
18238793
[PubMed - indexed for MEDLINE]
Free Article
2.

Signalling, inflammation and arthritis: Crossed signals: the role of interleukin-15 and -18 in autoimmunity.

Carroll HP, Paunovic V, Gadina M.

Rheumatology (Oxford). 2008 Sep;47(9):1269-77. doi: 10.1093/rheumatology/ken257. Epub 2008 Jul 10. Review.

PMID:
18621751
[PubMed - indexed for MEDLINE]
Free Article
3.

IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.

Leng RX, Pan HF, Tao JH, Ye DQ.

Expert Opin Ther Targets. 2011 Feb;15(2):119-26. doi: 10.1517/14728222.2011.534461. Epub 2010 Nov 12. Review.

PMID:
21073280
[PubMed - indexed for MEDLINE]
4.

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.

Williams RO, Paleolog E, Feldmann M.

Curr Opin Pharmacol. 2007 Aug;7(4):412-7. Epub 2007 Jul 12. Review.

PMID:
17627887
[PubMed - indexed for MEDLINE]
5.

Novel pro-inflammatory interleukins: potential therapeutic targets in rheumatoid arthritis.

Bessis N, Boissier MC.

Joint Bone Spine. 2001 Dec;68(6):477-81. Review.

PMID:
11808983
[PubMed - indexed for MEDLINE]
6.

Th17 cytokines and their emerging roles in inflammation and autoimmunity.

Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M.

Immunol Rev. 2008 Dec;226:87-102. doi: 10.1111/j.1600-065X.2008.00712.x. Review.

PMID:
19161418
[PubMed - indexed for MEDLINE]
7.

Th17 cells in rheumatoid arthritis and systemic lupus erythematosus.

Pernis AB.

J Intern Med. 2009 Jun;265(6):644-52. doi: 10.1111/j.1365-2796.2009.02099.x. Review.

PMID:
19493058
[PubMed - indexed for MEDLINE]
8.

Molecular mechanisms of inflammatory bone damage: emerging targets for therapy.

Herman S, Krönke G, Schett G.

Trends Mol Med. 2008 Jun;14(6):245-53. doi: 10.1016/j.molmed.2008.04.001. Epub 2008 May 9. Review.

PMID:
18468489
[PubMed - indexed for MEDLINE]
9.

Targeting interleukin-21 in rheumatoid arthritis.

Yuan FL, Hu W, Lu WG, Li X, Li JP, Xu RS, Li CW, Chen FH, Jin C.

Mol Biol Rep. 2011 Mar;38(3):1717-21. doi: 10.1007/s11033-010-0285-x. Epub 2010 Sep 17. Review.

PMID:
20848219
[PubMed - indexed for MEDLINE]
10.

Regulation of cytokine production during phagocytosis of apoptotic cells.

Chung EY, Kim SJ, Ma XJ.

Cell Res. 2006 Feb;16(2):154-61. Review.

PMID:
16474428
[PubMed - indexed for MEDLINE]
Free Article
11.

A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.

Astry B, Harberts E, Moudgil KD.

J Interferon Cytokine Res. 2011 Dec;31(12):927-40. doi: 10.1089/jir.2011.0094. Review.

PMID:
22149412
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

The IL-23/Th(17) axis: therapeutic targets for autoimmune inflammation.

Kikly K, Liu L, Na S, Sedgwick JD.

Curr Opin Immunol. 2006 Dec;18(6):670-5. Epub 2006 Sep 28. Review. Erratum in: Curr Opin Immunol. 2007 Feb;19(1):111.

PMID:
17010592
[PubMed - indexed for MEDLINE]
13.

IL-17 and IL-22: siblings, not twins.

Eyerich S, Eyerich K, Cavani A, Schmidt-Weber C.

Trends Immunol. 2010 Sep;31(9):354-61. doi: 10.1016/j.it.2010.06.004. Epub 2010 Aug 4. Review.

PMID:
20691634
[PubMed - indexed for MEDLINE]
14.

Interleukin-22: a likely target for treatment of autoimmune diseases.

Yang X, Zheng SG.

Autoimmun Rev. 2014 Jun;13(6):615-20. doi: 10.1016/j.autrev.2013.11.008. Epub 2014 Jan 10. Review.

PMID:
24418299
[PubMed - indexed for MEDLINE]
15.

Targeting cytokines of the interleukin-12 family in autoimmunity.

Kang BY, Kim TS.

Curr Med Chem. 2006;13(10):1149-56. Review.

PMID:
16719776
[PubMed - indexed for MEDLINE]
16.

Regulation of immune responses by interleukin-27.

Yoshida H, Miyazaki Y.

Immunol Rev. 2008 Dec;226:234-47. doi: 10.1111/j.1600-065X.2008.00710.x. Review. Erratum in: Immunol Rev. 2009 Jan;227(1):283. Yoshiyuki, Miyazaki [corrected to Miyazaki, Yoshiyuki].

PMID:
19161428
[PubMed - indexed for MEDLINE]
17.

Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy.

Bowman EP, Chackerian AA, Cua DJ.

Curr Opin Infect Dis. 2006 Jun;19(3):245-52. Review.

PMID:
16645485
[PubMed - indexed for MEDLINE]
18.

Update on cytokines in rheumatoid arthritis.

Brennan F, Beech J.

Curr Opin Rheumatol. 2007 May;19(3):296-301. Review.

PMID:
17414959
[PubMed - indexed for MEDLINE]
19.

Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting.

Anderson EJ, McGrath MA, Thalhamer T, McInnes IB.

Springer Semin Immunopathol. 2006 Jun;27(4):425-42. Epub 2006 May 6. Review. No abstract available.

PMID:
16738954
[PubMed - indexed for MEDLINE]
20.

Cytokines in the pathogenesis of rheumatoid arthritis.

McInnes IB, Schett G.

Nat Rev Immunol. 2007 Jun;7(6):429-42. Review.

PMID:
17525752
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk